Abstract Proton therapy is an advanced form of radiotherapy that allows control over the depth at which radiation energy is deposited in tissue. This can help deliver the prescribed dose to a tumor while reducing exposure to some surrounding healthy tissues. Its main physical advantage arises from the Bragg peak. This article discusses the underlying physics, treatment delivery, potential benefits, and challenges involving planning, accuracy, and cost. It emphasizes that clinical benefit varies according to the individual case. Keywords: Proton therapy, Bragg peak, medical physics, radiation dose, cancer treatment. 1. Introduction Radiotherapy is a major component of treatment for many cancers. Common techniques use high-energy photons, which deposit radiation dose in both the tumor and tissues along the beam path. Protons have a finite penetration range determined by their energy, allowing a reduction in dose beyond the treatment target. However, selecting the appropriate technique requires consideration of tumor location, patient characteristics, and the quality of competing treatment plans. 2. Physical Principles and the Bragg Peak A proton is a positively charged particle that gradually loses energy as it travels through tissue, mainly through interactions producing ionization and excitation. Energy deposition increases near the end of its path, forming a high-dose region called the Bragg peak, followed by a steep dose decrease. Increasing proton energy enables deeper penetration. Because a tumor occupies a three-dimensional volume, multiple energies are used to distribute dose across different depths and cover the target. This does not eliminate radiation outside the tumor: tissues in front of it receive an entrance dose, and scattering and other interactions affect the beam within the body. 3. Beam Production and Treatment Delivery Protons are accelerated using equipment such as cyclotrons or synchrotrons, transported to the treatment room, and directed toward the target. One delivery method is pencil beam scanning, in which a narrow beam moves across successive spots while changes in energy provide coverage at different depths. Intensity-modulated proton therapy (IMPT) optimizes dose distribution by adjusting beam and spot weights. Before treatment, medical images are used to identify the tumor and sensitive organs and calculate the planned dose distribution. 4. Potential Advantages and Applications The principal advantage is the potential to reduce radiation exposure to healthy tissues, particularly when tumors lie near sensitive organs. This is especially relevant in children because their organs are developing and they may live for many decades after treatment. Reducing exposure may help lower certain late complications and second-cancer risks, although these outcomes require long-term follow-up. Proton therapy may reduce some adverse effects in selected patients, but it does not guarantee higher cure rates for every cancer. Comparisons should also consider modern photon techniques, which can achieve highly conformal dose distributions. 5. Physical and Clinical Challenges Range uncertainty is a major concern. Differences in tissue density or changes in patient anatomy can alter where protons stop. Respiratory motion can also change tumor position, requiring appropriate motion management and verification that the treatment plan remains reliable. Other challenges include substantial installation and operating costs, specialized staffing, and rigorous quality assurance. Demonstrating clinical superiority requires studies comparing tumor control, complications, and quality of life. Trials comparing proton and photon therapy for breast cancer illustrate this need for direct clinical evaluation. 6. Future Directions and Conclusion Further progress depends on improved imaging, dose calculation, robust planning under uncertainty, and adaptation to anatomical changes during treatment. Proton therapy’s central value lies in improving the balance between tumor coverage and healthy-tissue protection. Its use should therefore follow an individualized assessment supported by treatment-plan quality and clinical evidence, alongside continued research to identify patients most likely to benefit. Almustaqbal University – The First University in Iraq